According to Bristol-Myers Squibb's latest financial reports and stock price the company's current Operating Margin is 19.24%. At the end of 2022 the company had an Operating Margin of 16.71%.
Year | Operating Margin | Change |
---|---|---|
2022 | 16.71% | -4.29% |
2021 | 17.46% | -208.03% |
2020 | -16.16% | -184.93% |
2019 | 19.03% | -28.57% |
2018 | 26.64% | 7.86% |
2017 | 24.70% | -18.89% |
2016 | 30.45% | 132.68% |
2015 | 13.09% | -12.73% |
2014 | 14.99% | -15.02% |
2013 | 17.64% | 32.87% |
2012 | 13.28% | -59.59% |
2011 | 32.86% | 5.46% |
2010 | 31.16% | 4.61% |
2009 | 29.79% | 12.13% |
2008 | 26.56% | 45.42% |
2007 | 18.27% | 24.18% |
2006 | 14.71% | -37.44% |
2005 | 23.51% | 3.14% |
2004 | 22.80% | 1.47% |
2003 | 22.47% | 53.78% |
2002 | 14.61% | -2.02% |
2001 | 14.91% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 22.88% | 18.92% | ๐บ๐ธ USA |
![]() Novartis NVS | 17.27% | -10.24% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | 34.61% | 79.89% | ๐บ๐ธ USA |
![]() AbbVie ABBV | 18.65% | -3.07% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 24.66% | 28.17% | ๐บ๐ธ USA |
![]() Amgen AMGN | 34.59% | 79.78% | ๐บ๐ธ USA |
![]() Sanofi SNY | 18.21% | -5.35% | ๐ซ๐ท France |
![]() Biogen BIIB | 31.30% | 62.68% | ๐บ๐ธ USA |
![]() Merck MRK | 27.73% | 44.13% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | 5.63% | -70.74% | ๐ฌ๐ง UK |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.